跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
DT-13
首页
药物
DT-13
DT-13
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Traditional Chinese medicine active ingredient composition for treating cardiovascular disease and use thereof
CN 101129395 A
申请人: UNIV CHINA PHARMA
优先权: 2007
CN
Nucleic acids specifically binding CGRP
CN 104136612 A
申请人: NOXXON PHARMA AG
优先权: 2013
CN
Liriope muscari steroidal saponin compound as well as preparation method and application of Liriope muscari steroidal saponin compound
CN 107383155 A
申请人: TASLY PHARMACEUTICAL GROUP CO
优先权: 2016
CN
Small nucleic acid molecule capable of inhibiting vascular restenosis and applications of small nucleic acid molecule
CN 106367417 A
申请人: AFFILIATED HOSPITAL OF NANTONG UNIV
优先权: 2016
CN
Application of liriope muscari baily saponins C to preparation of drug for treating prostatic cancer
CN 106943419 A
申请人: UNIV TIANJIN MEDICAL
优先权: 2017
CN
Application of liriope muscari saponin C in preparation of drugs for inhibiting pyroptosis of vascular endothelial cells
CN 118078845 A
申请人: UNIV DALIAN MEDICAL
优先权: 2024
CN
药物
反馈